FDA cracks down on websites selling illegal drugs
FDA recently stopped importation and sent warning letters to numerous online sellers of illegal opioids, oncology drugs and other medicines.
FDA recently stopped importation and sent warning letters to numerous online sellers of illegal opioids, oncology drugs and other medicines.
During Operation Pangea XI, FDA sent warning letters to 7 different networks operating 465 websites selling misbranded and unapproved drugs to US consumers. The sites sell “potentially dangerous, unapproved versions of opioid, oncology and antiviral prescription drugs,” FDA said in a statement.
Related: New naloxone provides more opioid overdose options
FDA also refused entry into the United States of 794 illegal drugs from web sites in the United Kingdom, India, and Canada. Plus, the agency brought 450 domain names, such as www.nextdaypills.com, to the attention of search engines and the appropriate domain name registries and registrars.
“The sale of potentially dangerous and counterfeit drugs by criminal networks on the internet is a large and growing threat to the public health,” said FDA Commissioner Scott Gottlieb, MD, in the statement from FDA.
Related: FDA warns CBD supplement maker
The illegal online pharmacies are often run by sophisticated criminal networks that “knowingly and unlawfully distribute illicit drugs, including potentially counterfeit medicines and controlled substances both on the surface and dark web,” Gottlieb added. “Consumers go to these websites believing that they’re buying safe and effective medications. But consumers are being put at risk by individuals who put financial gains above patient safety.”
Gottlieb said he is particularly concerned about the ease with which consumers can gain access to controlled substances and prescription opioids online. “This is one reason why we’ve stepped up our efforts, both from a policy and enforcement standpoint, to take these bad actors down.”
FDA provides consumers with information to identify an illegal online pharmacy and information on how to buy medicine safely online through BeSafeRx: Know Your Online Pharmacy.
Read more: FDA warns about fraudulent flu products
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
July 24th 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More
Sarepta to Pause Shipments of the Gene Therapy Elevidys
July 22nd 2025Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators while they address a safety labeling update about the risk of acute liver disease related to Elevidys.
Read More
